HIGHLIGHTS
- who: Giorgia Montrucchio from the University of California, San Francisco, United States have published the research work: Effectiveness of mid-regional pro-adrenomedullin, compared to other biomarkers (including lymphocyte subpopulations and immunoglobulins), as a prognostic biomarker in COVID-19 critically ill patients: New evidence from a 15-month observational prospective study, in the Journal: (JOURNAL)
- what: This study has limitations: it is a monocentric experience (although in different ICUs); it refers to a highly complex university center, receiving critical patients as secondary hospitalization and vv-ECMO support; the high mortality of patients and their turn . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.